Gene

VHL - Von Hippel-Lindau syndrome

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 616

VHL - Von Hippel-Lindau syndrome



€ 616

VHL - Von Hippel-Lindau syndrome

This test is available for the following conditions:

  • Conditions > Endocrine > Von Hippel-Lindau syndrome
  • Conditions > Renal / Nephrological > Von Hippel-Lindau syndrome
  • Conditions > Oncogenetics > Von Hippel-Lindau syndrome
  • Conditions > Vision impairment / blindness > Von Hippel-Lindau syndrome

This product is also part of the following panels:

  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • panel paragangliomas / pheochromocytomas (SDHA,SDHB,SDHC,SDHD,SDHAF2,RET,VHL,TMEM127,MAX,FH,MDH2)
  • WES ciliopathies (98.3% **)
  • WES hereditary cancer (98.3% **)
  • WES Mendelian inherited disorders (98.3% **)
  • WES skin disorders* (98.3% **)

** % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 608537
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 616